International Collaborators Focus on Biomarkers for Early Cancer Detection
The USA-Japan Workshop on Biomarkers for Cancer Early Detection presented research on the early detection and prevention of cancer.
Read MorePosted by Andy Lundin | Jun 15, 2022 | Cancer |
The USA-Japan Workshop on Biomarkers for Cancer Early Detection presented research on the early detection and prevention of cancer.
Read MorePosted by Chris Wolski | Jun 10, 2022 | Lung Cancer |
FoundationOne CDx has been approved by the FDA to be used as a companion diagnostic for the two indications of Rozlytrek (entrectinib).
Read MorePosted by Andy Lundin | Jun 6, 2022 | Lung Cancer |
A simple blood test could be an ideal predictor of whether cancer immunotherapy will be successful for a lung cancer patient.
Read MorePosted by Andy Lundin | Jun 3, 2022 | Cancer, Covid 19 |
A study from the American Cancer Society evaluated the impact of the pandemic on cancer screenings nationally through population-based data.
Read MorePosted by Chris Wolski | Jun 1, 2022 | Molecular Diagnostics |
The VALID study was designed to investigate the effectiveness in determining the risk that a lung allograft is being rejected.
Read More